Over 25,000 people with Type 1 diabetes took advantage of expanded access arrangements for continuous glucose monitoring products in the program's first six months but uncertainty remains over the proposed 'tender'.
Australians rush to CGM but long shadow of the 'tender' still looms over providers
April 6, 2023 Latest NewsBioPharma
Latest Video
New Stories
-
Who remembers the 'Vancouver' poster? We have a rerun
September 22, 2026 - - Latest News -
If there is a productivity gain in the process, then it should be passed on
September 22, 2026 - - Latest News -
Given the official use of AI, a cease and desist would not be unreasonable
September 22, 2026 - - Latest News -
Treasury has moved on from the PBS, but the policies built on its error have not
September 21, 2026 - - Latest News -
Nyrada banks $12 million as directors contribute in nearly half
September 21, 2026 - - Australian Biotech -
Telix announces takeover of ITM to create a global radiopharmaceutical powerhouse
September 21, 2026 - - Australian Biotech -
Only 2 per cent of Australians can name the signs of a heart condition behind one in four strokes
September 21, 2026 - - Latest News
